Kathryn Edwards is the Vanderbilt vaccinologist and ACIP member who served on Pfizer's COVID vaccine data safety monitoring board despite prior paid consulting for the company.
Dr. Kathryn Edwards is the central example in this KB of the Regulatory Capture pattern: simultaneously serving as a principal investigator on clinical trials for childhood vaccines and as a voting member of FDA and CDC vaccine committees that voted to license and recommend those same vaccines — while receiving funding, consulting fees, lecture fees, and speakers' bureau payments from the pharma companies whose products were under evaluation.
From 1991 to 2000, Dr. Edwards served as principal investigator for clinical trials of:
During the same period, she was a voting member of:
These are the exact committees that voted to license and add to the schedule the vaccines she was trialing.
Disclosed in the fine print of her peer-reviewed studies from this period:
| Type | Companies |
|---|---|
| Research funding | Wyeth Lederle, Aventis, SmithKline Beecham, Merck |
| Consulting | Pasteur Mérieux Connaught, SmithKline Beecham, Wyeth Lederle |
| Lecture sponsorship | Pasteur Mérieux Connaught, Wyeth Lederle |
| Speakers' bureau | Connaught, Lederle-Praxis |
| Research contracts | Connaught, Lederle-Praxis |
The Congressional investigation identified only the Wyeth Lederle contract ($255,023/year, 1996–1998) and missed the more extensive conflicts listed above.
The 2000 Congressional Report on FDA-CDC Conflicts identified Edwards' $255,023/year Wyeth Lederle contract but characterized it as only a fraction of her actual conflicts. The report still reached damning conclusions about the committees' "loose standards" and failure to treat significant conflicts as conflicts.
Edwards is Siri's primary case study for the simultaneous triple role: (1) conducting industry-funded clinical trials, (2) sitting on the regulatory committees voting on those trials' products, and (3) receiving ongoing pharma patronage from the companies whose products she evaluated. She is described as walking in Stanley Plotkin's footsteps.
In 2020, Siri cross-examined Edwards on the stand before a jury in her capacity as one of five members of Pfizer's independent Data Safety Monitoring Board (DSMB) for the Covid-19 vaccine clinical trial. The DSMB's role was to independently assess safety during the trial. Key exchange:
Q: Isn't it true that you've also been an advisor to Pfizer?
A: Yes, sir. I have been an advisor to Pfizer, and I've been working very, very closely with Pfizer, particularly their COVID vaccines, and going over lots of reactions and adverse events. So yes, I am working and being paid by Pfizer for my assessment of vaccine safety.
Q: And that's supposed to be an independent Data Safety Monitoring Board, correct?
A: It is an independent Data Safety Monitoring Board.
Q: But isn't it true that directly before becoming a member of the independent Data Safety Monitoring Board of the Pfizer COVID-19 vaccine, you were an advisor to Pfizer?
A: Pfizer pays me to evaluate the safety of their vaccines because I'm an expert. So I do get paid to do the work that I've been doing, but I've been doing the work conscientiously and comprehensively.
Q: So you don't think that financial incentives can sway people's judgments at all?
A: It does not sway my judgments, sir.
Q: Why bother having an independent Data Safety Monitoring Board? Why doesn't Pfizer just have some of its employees on it?
A: Because we are independent.
Q: Meaning folks who were never advisors to Pfizer?
A: We are independent from Pfizer in this assessment.
Siri argues this exchange illustrates a recurring pattern in which vaccinologists whose careers were built on pharmaceutical industry funding serve in roles designated as "independent" — while maintaining the financial relationships that undermine that independence.
Regulatory Capture, Conflicts of Interest, Stanley Plotkin, 2000 Congressional Report on FDA-CDC Conflicts, FDA, CDC, Pre-Licensure Safety Testing, Pfizer
Frequently Asked Questions